Search results for "Urinary tract infections"
‘UTI’ an overused diagnosis in the era of the microbiome
An evolving understanding of urinary tract infections has led one expert to describe them as an “ambiguous, expansive, overused diagnosis” that can lead to the myriad harms of antibiotic overtreatment.
https://immattersacp.org/archives/2018/02/uti-an-overused-diagnosis-in-the-era-of-the-microbiome.htm
1 Feb 2018
Prescribing for opioid addiction meds, CNS suppressants
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/11/prescribing-for-opioid-addiction-meds-cns-suppressants.htm
1 Nov 2017
High-value care a focus at Hospital Medicine 2017
Hospital Medicine 2017 featured advice on providing high-value care, from how to talk about the concept with patients to which tests and screens to give and which drugs to stop.
https://immattersacp.org/archives/2017/07/high-value-care-a-focus-at-hospital-medicine-2017.htm
1 Jul 2017
Managing superbugs in your community
General internists are poised to assume a key role in tackling the increasingly formidable threat of antimicrobial resistance.
https://immattersacp.org/archives/2017/05/superbugs.htm
1 May 2017
Label change for pioglitazone-containing medications
This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017
Botulinum toxin injection has small but uncertain clinical benefit when compared to sacral neuromodulation for refractory incontinence
Authors noted that while the difference was statistically significant, it had uncertain clinical importance, and patients who received injections were more likely to develop urinary tract infections and to need transient self-catheterization.
https://immattersacp.org/weekly/archives/2016/10/18/4.htm
18 Oct 2016
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016
New safety labels added to entire class of fluoroquinolones
Oral and injectable fluoroquinolones are associated with side effects involving tendons, muscles, joints, nerves, and the central nervous system, an FDA safety review found. These side effects may occur hours to weeks after use and can be permanent.
https://immattersacp.org/weekly/archives/2016/08/02/5.htm
2 Aug 2016
Warning on an antipsychotic; generic rosuvastatin approval
This update covers a warning that aripiprazole may be associated with compulsive or uncontrollable urges, as well as approval of the first generic version of rosuvastatin tablets.
https://immattersacp.org/archives/2016/07/fda.htm
1 Jul 2016
What economic theory can teach us about retail clinics
As clinicians continue to debate the merits and limitations of retail clinics, it is increasingly clear that they are here to stay. Although some concerns about this trend have merit, retail clinics could also create positive disruption for the medical community.
https://immattersacp.org/archives/2016/06/policy.htm
1 Jun 2016